Brief Information of the Cell Line and Protein
Cell Line ID: CL000017 , HeLa
Synonyms
HELA
Hela
He La
He-La
HeLa-CCL2
Henrietta Lacks cells
Helacyton gartleri
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0030
Protein ID: PT04261 , Neurogenic locus notch homolog protein 3
Gene Name NOTCH3
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q9UM47
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000017  Protein ID: PT04261
 
Compound ID Compound Name Compound Formula
CP0399659
(2R,3R)-2-(4-fluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C29H26F4N4O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0410890
(2R,3R)-2-(2,4-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C29H25F5N4O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0476835
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-yl-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C28H33F3N4O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0542514
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C30H29F3N4O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0409974
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethyl)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C30H26F6N4O3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0409975
(2R,3R)-2-(3,5-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C29H25F5N4O3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0566534
(2R,3R)-2-(3,4-difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C29H25F5N4O3
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0399658
(2S,3R)-3-(2,2-dimethylpropyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-ylbutanediamide
   Show/Hide
C30H40N4O3
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0410889
(2R,3R)-2-(3-methyl-1,2-oxazol-4-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C27H26F3N5O4
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0476836
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(2-methylpropyl)-2-pentan-3-ylbutanediamide
   Show/Hide
C29H38N4O3
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0428750
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethoxy)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C30H26F6N4O4
 1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0486923
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenyl-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C29H27F3N4O3
 1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0471072
(2R,3R)-2-(4-methoxyphenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C30H29F3N4O4
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0542515
(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-propyl-3-(2,2,2-trifluoroethyl)butanediamide
   Show/Hide
C25H27F3N4O3
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0472376
(2R,3R)-2-(1,2-oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C25H22F3N5O4
 1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0481233
(2R,3R)-2-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C27H26F3N5O4
 1
1
IC50 = 62 nM
   TI
   LI
   LO
   TS
CP0400691
(2R,3R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C26H25F3N6O4
 1
1
IC50 = 119 nM
   TI
   LI
   LO
   TS
CP0399657
(2R,3R)-2-(1,3-oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C25H22F3N5O4
 1
1
IC50 = 161 nM
   TI
   LI
   LO
   TS
CP0381969
(2R,3R)-2-(1,2,4-oxadiazol-3-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C24H21F3N6O4
 1
1
IC50 = 656 nM
   TI
   LI
   LO
   TS
CP0480596
(2R,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylsulfonylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide
   Show/Hide
C30H29F3N4O5S
 1
1
IC50 = 2241 nM
   TI
   LI
   LO
   TS